Inventor · disambiguated record
Lawrence Charnas
Also filed as: CHARNAS LAWRENCE
10 granted patents·7 pending applications·69 citations·filing 2011–2025
89Inventor score
Files withSHIRE HUMAN GENETIC THERAPIES9TAKEDA PHARMACEUTICALS CO4SYNAGEVA BIOPHARMA CORP2CALIAS PERICLES1SALAMAT-MILLER NAZILA1
Top patents by PatentIndex Score
17 records- 0193US2025161417A1Methods and compositions for cns delivery of arylsulfatase aTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0292US2025375506A1Cns delivery of therapeutic agentsTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 0391US10456454B2CNS delivery of therapeutic agentsSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Oct 29, 2019·6 cites·27 claims
- 0491US9283181B2CNS delivery of therapeutic agentsCALIAS PERICLES·Filed 2011·Granted Mar 15, 2016·34 cites·6 claims
- 0590US10660944B2Stable formulations for CNS delivery of arylsulfatase ASHIRE HUMAN GENETIC THERAPIES·Filed 2018·Granted May 26, 2020·5 cites·23 claims
- 0689US11471516B2CNS delivery of therapeutic agentsSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Oct 18, 2022·1 cites·17 claims
- 0785US12409210B2CNS delivery of therapeutic agentsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Sep 9, 2025·0 cites·5 claims
- 0881US8945542B2Methods for treating lysosomal acid lipase deficiencySYNAGEVA BIOPHARMA CORP·Filed 2013·Granted Feb 3, 2015·8 cites·3 claims
- 0980US9770410B2Methods and compositions for CNS delivery of arylsulfatase ASALAMAT-MILLER NAZILA·Filed 2011·Granted Sep 26, 2017·10 cites·32 claims
- 1079US9957324B2Anti-FLT-1 antibodies in treating duchenne muscular dystrophySHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted May 1, 2018·5 cites·7 claims
- 1175US12168041B2Methods and compositions for CNS delivery of arylsulfatase ATAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Dec 17, 2024·0 cites·6 claims
- 1273US10646554B2Methods and compositions for CNS delivery of arylsulfatase ASHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted May 12, 2020·0 cites·19 claims
- 1361US2020237883A1Stable formulations for cns delivery of arylsulfatase aSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 1460US2021163603A1Anti-flt-1 antibodies in treating duchenne muscular dystrophySHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 1559US2014377244A1Stable formulations for cns delivery of arylsulfatase aSHIRE HUMAN GENETIC THERAPIES·Filed 2012·Application pending·0 cites
- 1650US2018312593A1Anti-FLT-1 Antibodies in Treating Duchenne Muscular DystrophySHIRE HUMAN GENETIC THERAPIES·Filed 2018·Application pending·0 cites
- 1748US2013330317A1Methods for Treating Lysosomal Acid Lipase DeficiencySYNAGEVA BIOPHARMA CORP·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lawrence Charnas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →